RWE Case Studies from the front lines: Pfizer, Baxter, and BCBS talk Real-World Evidence. Will you be there to hear? Join our futuristic and extraordinary free (yes, FREE) 1st Virtual HEOR Conference: “Real World Evidence Virtual Summit: Practical Strategies for Addressing the Needs of Multiple Stakeholders”, December 11, 2014, 8am-5pm ET. Register today!
HEOR & Market Access Writing Workshop: 1st Annual Summit for both HEOR execs and aspiring HEOR med writers in industry, agencies, and consulting companies. March 26-27, 2015, Philadelphia. Learn more.
|IN THIS ISSUE|
|SPOTLIGHT 1 OF THE WEEK||SPOTLIGHT 2 OF THE WEEK|
|HEOR and Market Access Writing Workshop Aims to Help Improve Communication Tools.|
Wish your manuscripts, white papers, dossiers, and abstracts were written better, more robustly, with greater strategic focus? Now they can be, once you and your writers attend this 1-day course in Philadelphia, March 26-27, 2015.
Read more about Scotland’s new ‘Pay If You Clear’ scheme, which is still awaiting a formal decision by NHS Scotland. (Source: Reevel Alderson, BBC News Scotland, 10/13/14).
Orphan Drug Market Access: Payer Insights on the Present and Future is a report that examines the regulation, pricing, reimbursement, players and stakeholder/payer interests that are shaping the current and future direction of the orphan drug sector. This report offers insights from US and European healthcare payers and includes illustrative case studies that highlight key aspects of the orphan drug market. (Source: FirstWord, October 2014).
View multiple presentations from a recent conference.
A new Manhattan Research study from Decision Resources Group designed to address the unique challenges faced by marketers targeting formulary decision makers has found that P&T Committee Members are Shifting the Channels they use to gather information and are relying more and more on digital resources. Learn more on the key findings of the Taking the Pulse Formulary Decision Makers 2014 study. (Source: manhattanRESEARCH).
ISPOR’s Asia Consortium annual roundtable on ‘Health Technology Assessment Capacity Building in Asia’ was recently held in Bejing. Over 25 representatives attended with discussions on how to sustain and strengthen capacity in Asia, How to move forward, and some common challenges that will have to be faced. (Source: News Across Asia, Summer 2014, pg 9).
This whitepaper from eyeforpharma demonstrates innovation and change to pharma’s traditional pill-based model in order to help you transform your own strategies to keep up with the shift in the market place, towards a truly patient-centric model. (Source: eyeforpharma, 2014).
While Hong Kong is now part of China, the two countries’ pharmaceutical markets are independent, as are their pricing and reimbursement processes. It is essential for foreign manufacturers to have an understanding of each country’s regulatory and reimbursement systems. (Source: Jasmine Knight, George Papadopoulos, Xcenda).
Listen to Dr Patti Peeples discuss the history of health economics in the US and the ethical dilemmas of pricing pharmaceuticals, in this podcast from Relentless Health Value. (Source: relentlesshealthvalue, 10/16/14).
Nominations can be emailed, along with a curriculum vita, and will be taken until January 2, 2015. (Source: ISPOR, 2014).
|Link of the Week||Conference of the Week||Webinar of the Week|
|Xcenda Global Expertise and Insights featured at ISPOR Amsterdam.|
Join Xcenda’s Global HEOR consultants as they demonstrate their global perspective, as well as findings from the latest evidence-based research at ISPOR’s 17th Annual European Congress from 8-12, November, 2014.